We analyzed HIV env and nef sequences from plasma, PBMCs, and tumor biopsies before ART initiation (baseline) and then in PBMCs and tumors after ~180–280 days of ART (post-treatment). The gene discussed is ERVW-1; the disease is neoplasm.